Operating Lease, Payments in USD of OnKure Therapeutics, Inc. from Q1 2022 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
OnKure Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and change rate from Q1 2022 to Q1 2025.
  • OnKure Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2025 was $140K, a 164% increase year-over-year.
  • OnKure Therapeutics, Inc. annual Operating Lease, Payments for 2024 was $315K, a 50% increase from 2023.
  • OnKure Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $210K, a 58% decline from 2022.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Change (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Change (%)

OnKure Therapeutics, Inc. Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $140K +$87K +164% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q1 2024 $53K -$89K -62.7% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q1 2023 $511K $142K +$11K +8.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $500K $169K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $100K Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $100K Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $131K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11

OnKure Therapeutics, Inc. Annual Operating Lease, Payments (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $315K +$105K +50% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-10
2023 $210K -$290K -58% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-10
2022 $500K Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.